Large-scale testing (Phase 3)Study completedNCT02096263
What this trial is testing
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Who this might be right for
PoliomyelitisDiphtheriaHaemophilus Influenzae Type b+3 more
GlaxoSmithKline 585